Nuances in Efficacy, MACE Risk Revealed Between JAKi, TNFi

Three studies provide more data on risk for major adverse cardiovascular events with JAK inhibitors vs TNF inhibitors, as well as their efficacy in patients with different levels of risk.
Medscape Medical News

source https://www.medscape.com/viewarticle/992879?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?